Apple Vs Samsung Ad: Ken Segall Talks Apple vs. Samsung on Advertising Front

Page 1 of 2

Apple Vs Samsung Ad: Many people know Ken Segall as the guy who came up with the name iMac for Apple Inc. (NASDAQ:AAPL) while also working on its “Think Different” campaign while part of the advertising agency TBWAChiatDay.

A Leading Company Cheaper Than 90% Of Blue Chips... And It Recently Bounced 12%Apple is actually the smart money’s second favorite publicly traded company (see why it’s important to pay attention to hedge fund activity).

As you can imagine, Segall still keeps a close eye on the Cupertino-based company. Often times, he will share his opinion on his official blog.

Most recently, he posted this article: Apple battling where it used to crush

As you can probably tell from the title, Segall goes into great depth about Apple Inc. (NASDAQ:AAPL) and its struggles against the competition. Sure, the company is still holding its own but there is no denying the fact that competition has heated up.

Here is what Segall had to say:

“No matter what brand I’m working with, technology or otherwise, it’s astounding how many times I hear marketing people cite the Apple example to make a point. Apple’s advertising history is as famous as its products.

But something’s changed.

While you can still argue that Macs and i-devices have a ton of appeal, you can’t argue that Apple is still untouchable when it comes to advertising.

The fact is, it is being touched — often and effectively — by none other than Samsung.”

Once again, we have somebody who is touching on the fact that Samsung is pushing Apple to its limit. This is something that has been discussed, time and time again, as the company takes direct aim at Apple. Yesterday, for example, we wrote about the Samsung Galaxy Note 8.0 taking direct aim at the iPad mini.

So, how is Samsung becoming more effective on the advertising front? Here is what Segall added:

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!